Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacoeconomic considerations with statin therapy.

Katie M Speidel1, Daniel E Hilleman

  • 1The Cardiac Center of Creighton University, 3006 Webster Street, Omaha, NE 68131-2044, USA. katie.speidel@cardiac.creighton.edu

Expert Opinion on Pharmacotherapy
|June 30, 2006
PubMed
Summary

Statins effectively reduce cardiovascular events and mortality, proving cost-effective. Current research emphasizes optimizing statin therapy with high-intensity dosing for greater low-density lipoprotein cholesterol reduction and patient benefit.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lp(a): A potentially modifiable cardiovascular risk factor.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same author

Assessing pharmacists' knowledge and practices involving dietary supplement omega-3 fatty acids.

Journal of clinical lipidology·2025
Same author

Drug Interactions With Excessive Daytime Sleepiness Treatments.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians·2025
Same author

A narrative review of drugs targeting inflammation in vascular disease.

Postgraduate medicine·2025
Same author

A Clinicians Guide to Recommending Common Cholesterol-Lowering Dietary Supplements.

American journal of cardiovascular drugs : drugs, devices, and other interventions·2024
Same author

Elevated Lp(a): Guidance for Identifying and Managing Patients.

Southern medical journal·2024

Area of Science:

  • Cardiovascular Medicine
  • Pharmacoeconomics
  • Clinical Pharmacology

Background:

  • Statins are proven to reduce morbidity and mortality in diverse patient populations.
  • Previous economic evaluations confirmed the cost-effectiveness of statins based on mortality trials.
  • Placebo-controlled trials offer limited guidance for current statin selection decisions.

Purpose of the Study:

  • To review the evolving landscape of statin therapy optimization.
  • To highlight the need for economic analyses of comparative statin studies.
  • To inform drug therapy selection and formulary decisions.

Main Methods:

  • Review of recent clinical trials comparing different statin intensities.
  • Analysis of findings regarding low-density lipoprotein cholesterol reduction efficacy.

Related Experiment Videos

  • Identification of the gap in published economic evaluations for comparative studies.

    • Main Results:

    • More intensive statin therapy, with higher doses, yields greater low-density lipoprotein cholesterol reduction and clinical benefit.
    • Statins demonstrating superior efficacy in lowering low-density lipoprotein cholesterol are preferred.
    • Economic analyses of these comparative studies are currently lacking.

    Conclusions:

    • Optimizing statin therapy requires considering high-intensity regimens for enhanced patient outcomes.
    • Comparative efficacy in low-density lipoprotein cholesterol reduction is a key factor in selecting statins.
    • Urgent need for pharmacoeconomic studies to guide evidence-based statin selection and formulary placement.